Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - OPERATING INCOME
Operating Income REGN - Regeneron Pharmaceuticals, Inc.
3.99 B
LAST VALUE
-8.23%
2 YEAR CAGR
12.55%
5 YEAR CAGR
16.88%
10 YEAR CAGR